Views & analysis -

Trending

Latest Views & analysis

in Views & Analysis
2021 market access prospects for France
March 1, 2021 Share
X
2021 market access prospects for France
https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-france/
in Patients
Health at every size – making medicine weight inclusive
February 26, 2021 Share
X
Health at every size – making medicine weight inclusive
https://pharmaphorum.com/patients/health-at-every-size-making-medicine-weight-inclusive/
in Views & Analysis
Expediting innovation in the rare disease domain
February 26, 2021 Share
X
Expediting innovation in the rare disease domain
https://pharmaphorum.com/r-d/views-analysis-r-d/expediting-innovations-in-rare-disease-domain/
in Views & Analysis
Deep Dive: Research and Development
February 26, 2021 Share
X
Deep Dive: Research and Development
https://pharmaphorum.com/r-d/views-analysis-r-d/deep-dive-research-and-development/

Expediting innovation in the rare disease domain

Expediting innovation in the rare disease domain

Rare diseases affect a fraction of the population – 450 million+ people globally. However, its effects can be

X

Expediting innovation in the rare disease domain

https://pharmaphorum.com/r-d/views-analysis-r-d/expediting-innovations-in-rare-disease-domain/

Deep Dive: Research and Development

Deep Dive: Research and Development

Pharma’s historic R&D efforts have given us some light at the end of the COVID tunnel. Now it’s

X

Deep Dive: Research and Development

https://pharmaphorum.com/r-d/views-analysis-r-d/deep-dive-research-and-development/

Why we need research into the mental health impact of a rare disease diagnosis

Why we need research into the mental health impact of a rare disease diagnosis

Rare diseases impact between 3.5%-5.9% of the world’s population. For Rare Disease Day, RBW Consulting’s Emma Thorp discusses

X

Why we need research into the mental health impact of a rare disease diagnosis

https://pharmaphorum.com/views-and-analysis/the-mental-health-impact-of-a-rare-disease-diagnosis/

Recommended authors

More Views & Analysis

Roche on COVID-19 healthcare and testing: the pharmaphorum podcast

Roche on COVID-19 healthcare and testing: the pharmaphorum podcast

For episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and

X

Roche on COVID-19 healthcare and testing: the pharmaphorum podcast

https://pharmaphorum.com/podcast/roche-covid-health-testing/

A history of Johnson & Johnson

Set up by three brothers back in 1886, Johnson & Johnson continues to keep evolving

X

A history of Johnson & Johnson

https://pharmaphorum.com/views-analysis-sales-marketing/a-history-of-johnson-johnson/

Building a better future for people with rare diseases in all four UK nations

Building a better future for people with rare diseases in all four UK nations

How has rare disease care changed over the last few years? And what might we expect from the

X

Building a better future for people with rare diseases in all four UK nations

https://pharmaphorum.com/views-analysis-patients/building-a-better-future-for-people-with-rare-diseases-in-all-four-uk-nations/

Rare disease insights from the patient community

Rare disease insights from the patient community

To help pharma companies understand what life is really like for patients with a rare disease, a new

X

Rare disease insights from the patient community

https://pharmaphorum.com/views-and-analysis/rare-disease-insights-from-the-patient-community/

2021 market access prospects for Spain

2021 market access prospects for Spain

2021 will be the year when big market access changes – including the far wider use of health

X

2021 market access prospects for Spain

https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-spain/

2021 market access prospects for Germany

2021 market access prospects for Germany

The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG –

X

2021 market access prospects for Germany

https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-germany/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com